Standex (SXI) director awarded 639 restricted shares; owns 6,639
Standex International (SXI) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Standex International (SXI) reported an insider equity award. A director received a grant of 639 shares of common stock on 10/21/2025, coded as an acquisition under the company’s 2018 Omnibus Incentive Plan. The grant price was $0, and the restricted stock is scheduled to vest three years after the grant date.
Following this grant, the reporting person beneficially owns 6,639 shares, held directly. This filing reflects routine director compensation in equity rather than an open‑market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 639 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of Restricted Stock pursuant to the Company's 2018 Omnibus Incentive Plan that vests three years after the date of grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Standex (SXI) disclose in this Form 4?
What is the vesting schedule for the SXI restricted stock grant?
What was the transaction price for the SXI equity award?
What transaction code appears on the SXI Form 4?
Which plan governed the SXI restricted stock grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.